2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours

M.S. Aapro; J. Bohlius; David A. Cameron; Lissandra Dal Lago; J. Peter Donnelly; N. Kearney; G. H. Lyman; R. Pettengell; V. C. Tjan-Heijnen; J. Walewski; Damien C. Weber; C. Zielinski

doi:10.1016/j.ejca.2010.10.013

2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours

M.S. Aapro, J. Bohlius, David A. Cameron, Lissandra Dal Lago, J. Peter Donnelly, N. Kearney, G. H. Lyman, R. Pettengell, V. C. Tjan-Heijnen, J. Walewski, Damien C. Weber, C. Zielinski

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	8-32
Journal	European Journal of Cancer
Volume	47
Issue number	1
DOIs	https://doi.org/10.1016/j.ejca.2010.10.013
Publication status	Published - Jan 2011

Keywords

Antineoplastic agents
Filgrastim
Granulocyte colony-stimulating factor
Lenograstim
Neoplasms
Neutropenia
Pegfilgrastim
Guideline

Access to Document

10.1016/j.ejca.2010.10.013

Cite this

Aapro, M. S., Bohlius, J., Cameron, D. A., Dal Lago, L., Donnelly, J. P., Kearney, N., Lyman, G. H., Pettengell, R., Tjan-Heijnen, V. C., Walewski, J., Weber, D. C., & Zielinski, C. (2011). 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours. European Journal of Cancer, 47(1), 8-32. https://doi.org/10.1016/j.ejca.2010.10.013

Aapro, M.S. ; Bohlius, J. ; Cameron, David A. ; Dal Lago, Lissandra ; Donnelly, J. Peter ; Kearney, N. ; Lyman, G. H. ; Pettengell, R. ; Tjan-Heijnen, V. C. ; Walewski, J. ; Weber, Damien C. ; Zielinski, C. / 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours. In: European Journal of Cancer. 2011 ; Vol. 47, No. 1. pp. 8-32.

@article{b50a01d93667458ba3ca0d2d211c59ad,

title = "2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours",

keywords = "Antineoplastic agents, Filgrastim, Granulocyte colony-stimulating factor, Lenograstim, Neoplasms, Neutropenia, Pegfilgrastim, Guideline",

author = "M.S. Aapro and J. Bohlius and Cameron, {David A.} and {Dal Lago}, Lissandra and Donnelly, {J. Peter} and N. Kearney and Lyman, {G. H.} and R. Pettengell and Tjan-Heijnen, {V. C.} and J. Walewski and Weber, {Damien C.} and C. Zielinski",

year = "2011",

month = jan,

doi = "10.1016/j.ejca.2010.10.013",

language = "English",

volume = "47",

pages = "8--32",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "ELSEVIER SCI LTD",

number = "1",

}

Aapro, MS, Bohlius, J, Cameron, DA, Dal Lago, L, Donnelly, JP, Kearney, N, Lyman, GH, Pettengell, R, Tjan-Heijnen, VC, Walewski, J, Weber, DC & Zielinski, C 2011, '2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours', European Journal of Cancer, vol. 47, no. 1, pp. 8-32. https://doi.org/10.1016/j.ejca.2010.10.013

2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours. / Aapro, M.S.; Bohlius, J.; Cameron, David A.; Dal Lago, Lissandra; Donnelly, J. Peter; Kearney, N.; Lyman, G. H.; Pettengell, R.; Tjan-Heijnen, V. C.; Walewski, J.; Weber, Damien C.; Zielinski, C.

In: European Journal of Cancer, Vol. 47, No. 1, 01.2011, p. 8-32.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours

AU - Aapro, M.S.

AU - Bohlius, J.

AU - Cameron, David A.

AU - Dal Lago, Lissandra

AU - Donnelly, J. Peter

AU - Kearney, N.

AU - Lyman, G. H.

AU - Pettengell, R.

AU - Tjan-Heijnen, V. C.

AU - Walewski, J.

AU - Weber, Damien C.

AU - Zielinski, C.

PY - 2011/1

Y1 - 2011/1

KW - Antineoplastic agents

KW - Filgrastim

KW - Granulocyte colony-stimulating factor

KW - Lenograstim

KW - Neoplasms

KW - Neutropenia

KW - Pegfilgrastim

KW - Guideline

U2 - 10.1016/j.ejca.2010.10.013

DO - 10.1016/j.ejca.2010.10.013

M3 - Article

VL - 47

SP - 8

EP - 32

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

IS - 1

ER -

Aapro MS, Bohlius J, Cameron DA, Dal Lago L, Donnelly JP, Kearney N et al. 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours. European Journal of Cancer. 2011 Jan;47(1):8-32. https://doi.org/10.1016/j.ejca.2010.10.013